Molecular diagnosis of B-and T-cell lymphomas: Fundamental principles and clinical applications

Clinical Chemistry

Volumn 43, Issue 10, 1997, Pages 1814-1823

  Rezuke, William N ^a   Abernathy, Evelyn C ^a   Tsongalis, Gregory J ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LYMPHOMA; CHROMOSOME TRANSLOCATION; CLONOGENESIS; DIAGNOSTIC TEST; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN GENE; MINIMAL RESIDUAL DISEASE; MOLECULAR BIOLOGY; NONHODGKIN LYMPHOMA; ONTOGENY; POLYMERASE CHAIN REACTION; PROTO ONCOGENE; REVIEW; SOUTHERN BLOTTING; T CELL LYMPHOMA; T LYMPHOCYTE RECEPTOR GENE;

EID: 0030858170     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.10.1814     Document Type: Review

References (43)

1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
2. Jaffe ES. The role of immunophenotypic markers in the classification of non-Hodgkin's lymphomas. Semin Oncol 1990;17:11-9.
3. Cossman J, Uppenkamp M, Sundeen J, Coupland R, Raffeld M. Molecular genetics and the diagnosis of lymphoma. Arch Pathol Lab Med 1988;112:117-27.
4. Campana D, Pui CH. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 1995;85:1416-34.
5. Medeiros LJ, Bagg A, Cossman J. Application of molecular genetics to the diagnosis of hematopoietic neoplasms. In: Knowles, D. M., ed. Neoplastic hematopathology. Baltimore: Williams and Wilkins, 1992:263-98.
6. Cooper MD. B lymphocytes. Normal development and function. N Engl J Med 1987;317:1452-6.
7. Sklar J. Antigen receptor genes: structure, function, and techniques for analysis of their rearrangements. In: Knowles DM, ed. Neoplastic hematopathology. Baltimore: Williams and Wilkins, 1992:215-44.
8. Foon KA, Todd RF. Immunologic classification of leukemia and lymphoma. Blood 1986;68:1-31.
9. Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood 1995;85:2654-70.
10. Royer HD, Reinherz EL. T lymphocytes. Ontogeny, function, and relevance to clinical disorders. N Engl J Med 1987;317:1136-42.
11. Gill JI, Gulley ML. Immunoglobulin and T cell receptor gene rearrangement. Hematol Oncol Clin North Am 1994;8:751-70.
12. Cossman J, Zehnbauer B, Garrett CT, Smith LJ, Williams M, Jaffe ES, et al. Gene rearrangements in the diagnosis of lymphoma/ leukemia. Guidelines for use based on a multiinstitutional study. Am J Clin Pathol 1991;95:347-54.
13. Presnell SC. Nucleic acid blotting techniques. In: Coleman WB, Tsongalis GJ, eds. Molecular diagnostics for the clinical laboratorian. Totowa, NJ: Humana Press, 1997:63-87.
14. Hodges KA, Kosciol CM, Rezuke WN, Abernathy EC, Pastuszak WT, Tsongalis GJ. Chemiluminescent detection of gene rearrangements in hematologic malignancy. Ann Clin Lab Sci 1996;26: 114-8.
15. Medeiros LJ, Weiss LM. The utility of the polymerase chain reaction as a screening method for the detection of antigen receptor gene rearrangements. Hum Pathol 1994;25:1261-3.
16. Macintyre EA. The use of the polymerase chain reaction in hematology. Blood Rev 1989;3:201-10.
17. Sioutos N, BaggA, Michaud GY, Irving SG, Hartmann DP, Siragy H, et al. Polymerase chain reaction versus Southern blot hybridization. Detection of immunoglobulin heavy-chain gene rearrangements. Diagn Mol Pathol 1995;4:8-13.
18. Weiss LM, Spagnolo DV. Assessment of clonality in lymphoid proliferations. Am J Pathol 1993;142:1679-82.
19. Segal GH, Jorgensen T, Scott M, Braylan RC. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: II. follicular lymphomas. Hum Pathol 1994;25:1276-82.
20. Sorsher DH. DNA amplification techniques. In: Coleman WB, Tsongalis GJ, eds. Molecular diagnostics for the clinical laboratorian. Totowa, NJ: Humana Press, 1997:89-101.
21. Algara P, Soria C, Martinez P, et al. Value of PCR detection of TCRγ gene rearrangements in the diagnosis of cutaneous lymphocytic infiltrates. Diagn Mol Pathol 1994;3:275-82.
22. McCarthy KP, Sloane JP, Kabarowski JHS, Matutes E, Wiedermann LM. The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders. Am J Pathol 1991;138:821-8.
23. Diss TC, Watts M, Pan LX, Burke M, Linch D, Isaacson PG. The polymerase chain reaction in the demonstration of monoclonality in T-cell lymphomas. J Clin Pathol 1995;48:1045-50.
24. Gaidano G, Dalla-Favera R. Protooncogenes and tumor suppressor genes. In: Knowles DM, ed., Neoplastic hematopathology. Baltimore: Williams and Wilkins, 1992:245-61.
25. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992;80:879-86.
26. Crisan D, Chen ST, Weil SC. Polymerase chain reaction in the diagnosis of chromosomal breakpoints. Hematol Oncol Clin North Am 1994;8:725-50.
27. Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992; 16:637-40.
28. Ngan BY, Nourse J, Cleary ML. Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas. Blood 1989; 73:1759-62.
29. Vandenberghe E. Mantle cell lymphoma. Blood 1994;8:79-87.
30. Komatsu H, Iida S, Yamamoto K, Mikuni C, et al. A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the bcl-1 gene. Blood 1994;84:1226-31.
31. Athan E, Foitl DR, Knowles DM. Bcl-1 rearrangement: frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin lymphomas. Am J Pathol 1991;138:591-9.
32. Molot RJ, Meeker TC, Wittwer CT, Perkins SL, Segal GH, Masih AS, et al. Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas. Blood 1994;83:1626-31.
33. Luthra R, Hai S, Pugh WC. Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma. Diagn Mol Pathol 1995;4:4-7.
34. Lim LC, Segal GH, Wittwer CT. Detection of bcl-1 gene rearrangement and B-cell clonality in mantle cell lymphoma using formalinfixed, paraffin-embedded tissues. Am J Clin Pathol 1995;104: 689-95.
35. Pinyol M, Campo E, Nadal A, Terol MJ, Jares P, Nayach I, et al. Detection of the bcl-1 rearrangements at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction. Am J Clin Pathol 1996;105:532-7.
36. Corradini P, Astolfi M, Cherasco C, et al. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood 1997;89: 724-31.
37. Knechtli CJC, Goulden NJ, Langlands K, Potter MN. The study of minimal residual disease in acute lymphoblastic leukemia. J Clin Pathol 1995;48:M65-73.
38. Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KL, Zipf TF. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med 1997;336: 317-23.
39. Greaves M. Silence of the leukemic clone. N Engl J Med 1997; 336:367-9.
40. Cross NCP, Feng L, Bungey J, Goldman JM. Minimal residual disease after bone marrow transplant for chronic myeloid leukemia detected by the polymerase chain reaction. Leuk Lymphoma 1993;11:39-43.
41. Miyamura K, Takeo T, Kataoka T, Tahara T, Tanimoto M, Saito H. Detection of minimal residual disease in Philadelphia positive acute lymphoblastic leukemia: rationale for bone marrow transplantation from the polymerase chain reaction point of view. Leuk Lymphoma 1993;11:181-189.
42. Negrin RS, Blume KG. The use of the polymerase chain reaction for the detection of minimal residual malignant disease. Blood 1991;78:255-8.
43. Sklar J. Polymerase chain reaction: the molecular microscope of residual disease. J Clin Oncol 1991;9:1521-4.